Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) Director Richard Buchholz bought 1,000 shares of the firm's stock in a transaction on Friday, March 13th. The stock was bought at an average price of $14.84 per share, with a total value of $14,840.00. Following the completion of the purchase, the director owned 13,666 shares of the company's stock, valued at $202,803.44. This trade represents a 7.90% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Shoulder Innovations Trading Down 0.5%
Shares of NYSE SI opened at $15.20 on Wednesday. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $17.94. The company has a market cap of $313.88 million and a price-to-earnings ratio of -0.07. The company has a current ratio of 11.07, a quick ratio of 9.55 and a debt-to-equity ratio of 0.11. The stock's 50 day simple moving average is $13.76 and its 200 day simple moving average is $13.85.
Shoulder Innovations (NYSE:SI - Get Free Report) last issued its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.04. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%.The firm had revenue of $14.42 million for the quarter, compared to analyst estimates of $12.69 million. Equities research analysts expect that Shoulder Innovations, Inc. will post -0.56 EPS for the current year.
Wall Street Analysts Forecast Growth
Several research analysts have commented on the stock. Weiss Ratings restated a "sell (e)" rating on shares of Shoulder Innovations in a research report on Monday, December 29th. The Goldman Sachs Group reissued a "buy" rating on shares of Shoulder Innovations in a report on Friday, January 9th. BTIG Research raised their target price on Shoulder Innovations from $23.00 to $24.00 and gave the company a "buy" rating in a research report on Wednesday, March 11th. Finally, Morgan Stanley lifted their target price on Shoulder Innovations from $18.00 to $23.00 and gave the company an "overweight" rating in a research note on Tuesday, December 2nd. Five analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $20.80.
Get Our Latest Report on SI
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in SI. Sectoral Asset Management Inc. raised its holdings in Shoulder Innovations by 14.4% during the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company's stock worth $7,042,000 after purchasing an additional 62,153 shares in the last quarter. Deerfield Management Company L.P. bought a new stake in shares of Shoulder Innovations in the 3rd quarter worth $6,056,000. Alyeska Investment Group L.P. acquired a new stake in shares of Shoulder Innovations in the third quarter valued at $5,667,000. TimesSquare Capital Management LLC bought a new position in Shoulder Innovations during the third quarter valued at about $4,799,000. Finally, Federated Hermes Inc. bought a new position in Shoulder Innovations during the third quarter valued at about $2,510,000.
Shoulder Innovations Company Profile
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
